BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 319 filers reported holding BIONTECH SE in Q4 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273 | -1.4% | 2,534 | -1.2% | 0.01% | +7.7% |
| Q2 2023 | $277 | -20.2% | 2,565 | -8.2% | 0.01% | -23.5% |
| Q1 2023 | $347 | +8.4% | 2,794 | +32.2% | 0.02% | 0.0% |
| Q4 2022 | $320 | -100.0% | 2,113 | -85.1% | 0.02% | -84.4% |
| Q3 2022 | $1,917,000 | -5.6% | 14,213 | +4.5% | 0.11% | +3.8% |
| Q2 2022 | $2,030,000 | +76.1% | 13,607 | +102.9% | 0.10% | +110.0% |
| Q1 2022 | $1,153,000 | -63.4% | 6,705 | -45.2% | 0.05% | -59.3% |
| Q4 2021 | $3,147,000 | +7.7% | 12,242 | +14.6% | 0.12% | -2.4% |
| Q3 2021 | $2,923,000 | +18.1% | 10,685 | -3.3% | 0.13% | +14.5% |
| Q2 2021 | $2,474,000 | +2070.2% | 11,050 | +952.4% | 0.11% | +1733.3% |
| Q1 2021 | $114,000 | +356.0% | 1,050 | +183.8% | 0.01% | +200.0% |
| Q2 2020 | $25,000 | – | 370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |